Case number 2:17-cv-12857
VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. ACTAVIS LABORATORIES FL, INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 19, 2022 | 23 | Notice of Appeal (Federal Circuit) (3) Docket Text: NOTICE OF APPEAL to Federal Circuit as to ([189] in 2:16-cv-09038-SRC-CLW) Order, ([187] in 2:16-cv-09038-SRC-CLW) Opinion, ([197] in 2:16-cv-09038-SRC-CLW, Order of Dismissal, ([188] in 2:16-cv-09038-SRC-CLW) Order, by ACTAVIS LABORATORIES FL, INC.. The Clerk's Office hereby certifies the record and the docket sheet available through ECF to be the certified list in lieu of the record and/or the certified copy of the docket entries. (dam, ) |
| Apr 18, 2018 | 22 | Order (7) Docket Text: ORDER that the above-captioned actions are hereby consolidated for all purposes, including trial. The Clerk shall close Civil Action No. 2:17-12857 (SRC)(CLW), which is consolidated into Civil Action No. 2:16-9038 (SRC)(CLW); Papers in Civil Action No. 2:16-9038 (SRC)(CLW) and Civil Action No. 2:17-12857 (SRC)(CLW) shall be filed only in Civil Action No. 2:16-9038 (SRC) CLW), etc. Signed by Magistrate Judge Cathy L. Waldor on 04/17/2018. (ek, ) |
| Apr 18, 2018 | N/A | Create Case Association (0) Docket Text: Cases associated: Create association to 2:16-cv-09038-SRC-CLW. (ek) |
| Apr 18, 2018 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated. (ek) |
| Apr 17, 2018 | N/A | Order (0) |
| Apr 17, 2018 | N/A | Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Magistrate Judge Cathy L. Waldor: Telephone Conference held on 4/17/2018. (tjg, ) |
| Mar 1, 2018 | 20 | Letter (2) Docket Text: Letter from William P. Deni, Jr, to Hon. Cathy L. Waldor re: update regarding the case schedule and discovery dispute. (DENI, WILLIAM) |
| Feb 28, 2018 | 19 | Scheduling Order (3) Docket Text: SCHEDULING ORDER: Telephone Conference, Plaintiff to initiate, set for 4/17/2018 at 2:30 PM before Magistrate Judge Cathy L. Waldor. Fact Discovery due by 8/10/2018. Motions to Add Parties and/or Amend Pleadings due by 4/5/2018. etc. Signed by Magistrate Judge Cathy L. Waldor on 2/28/18. (jbb) |
| Feb 27, 2018 | 18 | Stipulation (7) Docket Text: STIPULATION and [Proposed] Order Consolidating Cases for All Purposes by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC. (DENI, WILLIAM) |
| Feb 16, 2018 | 17 | Answer to Counterclaim (16) Docket Text: ANSWER to Counterclaim by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC.(DENI, WILLIAM) |
| Feb 7, 2018 | 16 | Letter (6) Docket Text: Letter from William P. Deni, Jr. to Honorable Cathy L. Waldor, U.S.M.J. re: case consolidation. (DENI, WILLIAM) |
| Feb 6, 2018 | 14 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC (LOWER, J.) |
| Feb 6, 2018 | 15 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by LAUREN BROPHY COOPER on behalf of PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC (COOPER, LAUREN) |
| Feb 5, 2018 | N/A | Order (0) |
| Feb 5, 2018 | N/A | Notice of Judicial Preferences (0) Docket Text: Notice of Judicial Preferences. Click here for the Judge's Individual Procedure Requirements. (tjg, ) |
| Feb 2, 2018 | 11 | Answer to Complaint (24) |
| Feb 2, 2018 | 12 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by ACTAVIS LABORATORIES FL, INC. identifying Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. as Corporate Parent.. (LATTIMORE, JASON) |
| Feb 2, 2018 | 11 | Main Document (24) Docket Text: ANSWER to Complaint , COUNTERCLAIM against All Plaintiffs by ACTAVIS LABORATORIES FL, INC.. (Attachments: # (1) Certificate of Service)(LATTIMORE, JASON) |
| Feb 2, 2018 | 10 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC. All Defendants. (DENI, WILLIAM) |
| Feb 2, 2018 | 11 | Certificate of Service (1) |
| Jan 19, 2018 | 9 | Stipulation of Dismissal (aty) (5) |
| Jan 19, 2018 | 9 | Main Document (5) Docket Text: STIPULATION of Dismissal Without Prejudice as to Actavis LLC, Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries Ltd. by ACTAVIS LABORATORIES FL, INC., ACTAVIS LLC, TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC.. (Attachments: # (1) Certificate of Service)(LATTIMORE, JASON) |
| Jan 19, 2018 | 8 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by JASON B. LATTIMORE on behalf of ACTAVIS LABORATORIES FL, INC., ACTAVIS LLC, TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. (LATTIMORE, JASON) |
| Jan 19, 2018 | 9 | Certificate of Service (1) |
| Dec 12, 2017 | 7 | AO120 Patent/Trademark Form (1) |
| Dec 12, 2017 | 7 | Main Document (1) Docket Text: AO120 Patent/Trademark Form filed. (Attachments: # (1) Exhibit Complaint) (ek) |
| Dec 12, 2017 | 6 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to ACTAVIS LABORATORIES FL, INC., ACTAVIS LLC, TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *ELISAVETA KALLUCI* (ek) |
| Dec 12, 2017 | 7 | Exhibit Complaint (131) |
| Dec 8, 2017 | 1 | Complaint (15) |
| Dec 8, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Stanley R. Chesler and Magistrate Judge Cathy L. Waldor. (ak, ) |
| Dec 8, 2017 | 5 | Corporate Disclosure Statement (aty) (1) Docket Text: Corporate Disclosure Statement by WYETH LLC identifying Pfizer Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Dec 8, 2017 | 4 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by PROGENICS PHARMACEUTICALS, INC. identifying Federated Investors Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Dec 8, 2017 | 3 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by SALIX PHARMACEUTICALS, INC. identifying Salix Pharmaceuticals, Ltd., Valeant Pharmaceuticals International, Biovail Americas Corp., V-Bac Holdings Corp., Valeant Canada LP, Valeant Pharmaceuticals International, Inc. as Corporate Parent.. (DENI, WILLIAM) |
| Dec 8, 2017 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by VALEANT PHARMACEUTICALS INTERNATIONAL, INC.. (DENI, WILLIAM) |
| Dec 8, 2017 | 1 | Local Civil Rule 10.1(a) Statement (3) |
| Dec 8, 2017 | 1 | Local Civil Rule 11.2 Certification (2) |
| Dec 8, 2017 | 1 | Main Document (15) Docket Text: COMPLAINT against ACTAVIS LABORATORIES FL, INC., ACTAVIS LLC, TEVA PHARMACEUTICALS INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC. ( Filing and Admin fee $ 400 receipt number 0312-8317781), filed by PROGENICS PHARMACEUTICALS, INC., SALIX PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., WYETH LLC. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Civil Cover Sheet, # (4) Local Civil Rule 11.2 Certification, # (5) Local Civil Rule 10.1(a) Statement)(DENI, WILLIAM) |
| Dec 8, 2017 | 1 | Civil Cover Sheet (1) |
| Dec 8, 2017 | 1 | Exhibit B (55) |
| Dec 8, 2017 | 1 | Exhibit A (55) |
| Dec 8, 2017 | 1 | Complaint* (1) |
